CNBC
3 weeks ago
CVS replaces CEO Karen Lynch with exec David Joyner as profits, share price suffer
David Joyner has replace Karen Lynch as CVS CEO, as the company's stock price and performance suffers.
Latest News
FDA eyes McDonald's supplier Taylor Farms as source of E. Coli outbreak
3 weeks ago
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
3 weeks ago
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
2 weeks ago
Palo Alto shares helped by contract news, Abbott Labs braces for lawsuit ruling
2 weeks ago
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
3 weeks ago